Compound Detail
CHEMBL5630470
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5630470 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RQICENDRWFKYPC-LLVKDONJSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
364.4
MW (Da)
2.30
ALogP
7
HBA
0
HBD
76.8
PSA (Ų)
0.65
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 5.45
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Neuromedin-K receptor CHEMBL4429 | IC50 | 5.45 | 5.45 | 3565.3 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Neuromedin-K receptor | IC50 | = | 3565.33 | nM | 5.45 | Antagonist activity at human NK3R expressed in HEK293T cells assessed as reducti... | 37247507 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37247507 | 10.1016/j.ejmech.2023.115486 | Neuromedin-K receptor | 2 |
Data from ChEMBL 36 via Core Engine